Background Irinotecan is a potent chemotherapeutic agent used as a neoadjuvant in colorectal cancer liver metastasis and significantly enhances five-year survival rates. Recently, irinotecan-associated hepatotoxicity was a significant concern. Given the limited study in this area, we aimed to identify risk factors associated with irinotecan-induced hepatotoxicity. Methods This is a retrospective cohort study at King Saud University Medical City in Riyadh. The study encompassed all adult cancer patients who received irinotecan treatment between Jun 2017 and December 2023. The clinical records of patients were reviewed to assess factors associated with hepatotoxicity. Time-to-event analyses were performed using time-varying exposure. Results The study includes 229 adult cancer patients who received irinotecan-based treatment. Median age was 58 years, and colorectal cancer was the most diagnosed type of cancer (68.6%). Over a median follow-up of 103 days, the incidence of hepatotoxicity was 19.2% (n=44). In the adjusted analysis, higher baseline AST was associated with an increased hazard of hepatotoxicity (HR = 1.01; 95% CI: 1.01–1.02; p = 0.001). Cumulative irinotecan dose showed an inverse association with hepatotoxicity, with lower hazards observed in the medium cumulative dose group (HR = 0.36, 95% CI: 0.14–0.91, p = 0.031) and high cumulative dose group (HR = 0.06, 95% CI: 0.01–0.48, p = 0.008) compared with the low cumulative dose group. Conclusion In summary, an inverse association was observed between cumulative irinotecan dose and hepatotoxicity. A higher baseline AST was also associated with hepatotoxicity, warranting careful assessment of pretreatment liver enzymes and closer monitoring during the early treatment period. Further studies are needed to validate these findings and investigate additional predictors of irinotecan-related hepatotoxicity.
BACKGROUND: Gastrointestinal Panel (GIP), allow rapid and comprehensive detection of enteric pathogens; however, evidence on their utility from Saudi Arabia is lacking. This study therefore aimed to assess the prevalence of enteric pathogens, determine the detection yield of the FilmArray GIP, and explore its potential impact on clinical management. METHODS: We conducted a retrospective cohort study at Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia, from January 2023 to December 2024. All adult patients (≥ 18 years) with suspected AGE tested using the FilmArray GIP were eligible for inclusion. Clinical and laboratory data, GIP findings, antimicrobial therapy, and clinical outcomes were extracted from electronic medical records. RESULTS: A total of 176 adult patients with AGE were included in this analysis. The FilmArray GIP detected bacterial pathogens in 86.4% of patients, while viral and parasitic agents were identified in 20.5% and 10.2% of the cohort, respectively. Co-detections were observed in 46.6% of patients, although their clinical relevance remains uncertain. Stool microscopy failed to detect any parasitic pathogens, whereas the multiplex panel identified parasites in 18 patients (p < 0.001). Detection of Salmonella was more than five times higher with the FilmArray GIP compared with stool culture (18.2% versus 3.4%; p < 0.001). The FilmArray GIP was associated with antimicrobial modifications, with no antibiotics prescribed in 30.1% of patients, whereas targeted antimicrobials were initiated in 27.3%. Notably, 8.5% of cases required transmission-based isolation, with Clostridioides difficile infections were more frequently associated with isolation compared with norovirus cases (42.3% versus 15.4%; p = 0.11). CONCLUSIONS: The FilmArray GIP demonstrated higher detection yield for enteric pathogens compared with conventional diagnostic techniques. Rapid identification of enteric pathogens was temporally associated with antimicrobial optimization and infection control decisions. Taken together, these findings highlight the potential role of syndromic molecular testing in the management of adult AGE. CLINICAL TRIAL NUMBER: Not applicable.
The Journal of Clinical Pharmacology · مجلد 66 (1) · e70139-e70139
Valproic acid (VPA) is highly protein-bound, thereby impacting its free fraction and clearance in hypoalbuminemia. There is limited data on VPA use in such patients. Thus, this study evaluates the impact of adjusted VPA concentration (aVPAc) in predicting effectiveness and adverse effects compared to total VPA (tVPA) levels in hypoalbuminemic patients. A retrospective cohort study involved adult patients with seizures or epilepsy between January 1, 2016, and December 31, 2022. The levels of tVPA and aVPA (adjusted for albumin) were compared using receiver operating characteristic curves, and AUC differences were assessed using the DeLong method. Safety endpoints included hepatotoxicity, hyperammonemia, hyponatremia, and thrombocytopenia, while effectiveness endpoints were seizure occurrence, status epilepticus, and the use of additional antiepileptic medications during hospitalization. Of the 1621 screened patients, 71 with hypoalbuminemia received VPA. An aVPAc threshold of 154.19 mg/dL demonstrated higher sensitivity (86%) but lower specificity (47%) for predicting hepatotoxicity compared to a tVPA threshold of 67.53 mg/dL (sensitivity: 71%, specificity: 72%). Although aVPAc yielded a comparable negative predictive value (96% vs 95%), tVPA showed superior positive predictive value (25% vs 18%) and a higher Youden index (0.43 vs 0.33), indicating better overall discriminatory performance; however, these findings did not achieve statistical significance. In contrast, an aVPAc threshold of 188 mg/dL showed a sensitivity of 100% and a specificity of 82% for predicting hyperammonemia, which is superior to the tVPA threshold of 74.32 mg/dL that has a sensitivity of 40% and a specificity of 88%. The aVPAc also achieved a higher Youden index of 0.82 compared to 0.28 for tVPA. Adjusted VPA concentrations showed greater sensitivity than tVPA in predicting hepatotoxicity and hyperammonemia, suggesting potential utility for ruling out these adverse effects in hypoalbuminemic patients. Further research with a larger sample size is needed to validate these findings.
BACKGROUND: The safety of morphine in acute pancreatitis (AP) remains controversial due to theoretical risks of exacerbating complications. This study evaluated whether early morphine use correlates with clinical deterioration in AP. METHODS: In this retrospective cohort study, 154 patients with AP (diagnosed per Revised Atlanta Criteria) treated at a tertiary center (2012-2024) were stratified by morphine use within 48 h of admission. The primary outcome was a composite of clinical deterioration (30-day mortality, mechanical ventilation, vasopressor use, surgery, prolonged hospitalization, CRP doubling, or new organ failure). Associations were assessed using multivariable logistic regression adjusted for age, sex, admission severity, and inflammatory markers. RESULTS: Of 154 patients, 53 received early morphine. Baseline age and sex distributions were similar between groups, but morphine recipients had lower mechanical ventilation rates (17.0% vs. 35.6%, p = 0.02) and higher hemoglobin (131.0 vs. 122.0 g/L, p = 0.01). Clinical deterioration occurred in 49.1% (morphine) vs. 62.4% (non-morphine), with no significant difference (adjusted OR = 0.61, 95% CI: 0.29-1.28, p = 0.19). High-dose opioids (MME ≥ 100, n = 24) showed no association with deterioration (adjusted OR = 0.92, 95% CI: 0.33-2.54, p = 0.87). Severity-adjusted analyses confirmed these findings. CONCLUSIONS: In this cohort, early morphine and opioid use were not associated with clinical deterioration in acute pancreatitis. These findings support the safety of early opioid analgesia for pain control in AP, although residual confounding cannot be excluded. Prospective studies are needed to confirm causality and inform guideline recommendations.
Saudi Pharmaceutical Journal · مجلد 33 (5) · 41-41
Antimicrobial resistance (AMR) is rising alarmingly in Saudi Arabia, as evidenced by surveillance data. This retrospective cohort study evaluated the association between parenteral antimicrobial use and bacterial resistance at King Khaled Hospital, Al-Kharj, using electronic health records. Linear regression analyzed antibiotic exposure-resistance relationships over 36 months (January 2022–December 2024). Eligible participants were hospitalized ≥ 48 h and received ≥ 1 parenteral antimicrobial. The required sample size was 384 (calculated via Cochran’s formula). Inclusion mandated laboratory-confirmed bacterial infections (positive cultures with susceptibility testing). Investigated pathogens included Escherichia coli , Klebsiella pneumoniae , Pseudomonas aeruginosa , Acinetobacter baumannii , and Staphylococcus aureus . Among 4,007 participants, 59.02% were female, and 73.07% were Saudis. Findings revealed severe AMR, particularly in Escherichia coli and Klebsiella pneumoniae , with high resistance to multiple antibiotic classes. Acinetobacter baumannii exhibited near-pan-drug resistance (> 90% resistance to most antibiotics). Imipenem use strongly correlated with Escherichia coli resistance (R 2 = 1.000, p-value = 0.009), indicating significant carbapenem-driven selection pressure. Meropenem exposure also closely linked to Klebsiella pneumoniae resistance (R 2 = 0.994, p-value = 0.050). Widespread resistance to β-lactams, fluoroquinolones, and aminoglycosides—combined with near-pan-resistant Acinetobacter baumannii —highlights escalating treatment challenges. Crucially, carbapenem usage (imipenem/meropenem) strongly predicted resistance in Escherichia coli and Klebsiella pneumoniae , reinforcing antimicrobial pressure’s role in resistance development. These results emphasize the urgent need for antimicrobial stewardship at King Khaled Hospital to curb carbapenem overuse and combat resistant infections.
Saudi Journal of Emergency Medicine · مجلد 6 (3) · 195-200
Background: Neuroimaging plays a critical role in the evaluation of patients presenting with new-onset seizures. This study aimed to explore the epidemiological characteristics of patients presenting to the emergency department (ED) with first-time seizures. Methods: This was a single-center, retrospective cohort study, utilizing data extracted from the electronic hospital system for adult patients who presented with new-onset seizures over a 5-year period. Results: The study included 323 patients (61% male), with a mean age of 43 years. Generalized tonic-clonic seizures were the most common seizure type (84%). Brain computed tomography (CT) scans were normal in 65% of cases, while 35% showed abnormalities, primarily post-stroke sequelae (10.5%), acute stroke (6.8%), and neoplasms (6.5%). Patients with abnormal CT findings were older and had more comorbidities. Logistic regression analysis identified age and focal seizures as significant predictors of abnormal CT findings, while a history of stroke was inversely associated. Conclusion: CT imaging identified abnormalities in 35% of patients with new-onset seizures, with age and focal seizures serving as key predictors. These findings support a risk-based approach to neuroimaging in the ED setting.
new-onset seizuresneuroimagingbrain computed tomographyemergency department
Journal of Family Medicine and Primary Care · مجلد 13 (11) · 5067-5071
Background: Bell's palsy (BP) is a cranial nerve disorder in which unilateral or bilateral paralysis of the facial nerve occurs. The study aims to study BP's characteristics, including its clinical manifestations, prognosis, and complications among adult patients aged 18 years and above. Methods: A retrospective study of adult patients diagnosed with BP in a primary care setting] [January 2015 to December 2022]. Results: The study included a total number of 92 patients with an incidence rate of 23 cases per 100,000 people. The mean age was 43.52 years. The most common symptoms reported were dropping of the mouth at 38.9%, loss of forehead muscle movement at 24.4%, loss of nasolabial fold at 22.2%, loss of facial expressions at 20%, and headache at 18.9%. Immunodeficiency affected 2.3% of the patients. The management of patients involved the use of steroids in 76.1% and the use of antiretroviral medications in 48.9%. Physiotherapy was used in 29.5%. The complete recovery rate during the first year was 90.8%. The rate of complete recovery within two years was 96.9%. Conclusion: The incidence of BP in the region seems to be similar to the incidence rate reported elsewhere in the world. The use of antiviral therapy seems to be high despite the controversy around the use of antivirals in the management of BP. The majority of patients with BP recover within the first year.
Journal of Clinical Medicine · مجلد 13 (22) · 6951-6951
Background: Resected rectal polyps with deep invasion into the submucosa (pT1b-sm2,3) or the muscle layer (pT2) are currently confronted with surgery due to non-curative resection. Aims: We evaluated the efficacy, safety, and locoregional control of adjuvant radiotherapy (RT) and/or chemotherapy (CT) following endoscopic KAR (knife-assisted resection) in patients with invasive early rectal cancers who are unwilling or unsuitable for additional surgical resection. Methods: Fifty-one patients with early rectal cancers, pT1b or pT2, underwent post-resection adjuvant RT and/or CT in 15 centers worldwide. “En bloc” macroscopic resection, R0 resection, recurrence rate, and adverse events following resection and adjuvant therapy were recorded in a multicenter retrospective cohort study. Results: Diagnostic staging (38/51, 75%) was the main reason for ELE. Macroscopic “en bloc” resection was demonstrated in 50/51 (98%), with an average follow-up of 20.6 months. Endoscopic recurrence occurred in 7/51 (13.7%) of patients, with mean time for diagnosis of recurrence at 8.9 months. Adjuvant therapy consisted of RT in 49.0% (25/51), CT in 11.8% (6/51), and combined CRT in 39.2% (20/51) of the cases. Perforation, severe post-procedural bleeding, and incontinence were the most frequent complications. The absence of superficial ulceration was associated with macroscopic complete resection, while the lesions with lower budding stage, clear lateral margins, lesion size < 40 mm, and needle-type knife used were associated with less endoscopic recurrencies. Conclusions: Our data investigated adjuvant RT and/or CT after endoscopic KAR of infiltrative rectal cancers (pT1bsm2,3-pT2) as being safe and effective for locoregional control and providing a non-surgical treatment option for patients with a non-curative resection.
early rectal canceradjuvant radiotherapyadjuvant chemotherapychemoradiotherapy
Journal of Lung Pulmonary & Respiratory Research · مجلد 11 (1) · 9-13
Background: Malignant pleural effusions (MPE) are common complications of advanced malignancy. The treatment of MPE is generally focused on palliation of respiratory symptoms. The main drawback of the traditional method of pleurodesis is the requirement for hospitalization. Objectives: To examine the safety, efficacy and economy of management of a dedicated MPE clinic. Methods and analysis: A retrospective cohort study was designed to compare complication rates, pleural effusion control, length of hospital stay, type of interventions, estimated hospital days saved between two three-year non-contemporary periods – before the implementation of MPE clinic and after. Results: Pre MPE clinic and MPE clinic group comprised of 115 and 161 patients respectively. The number of hospital admissions was lower in the MPE clinic period (42.4% vs 73.9%; p<0.0001) and the pleural effusion control was higher in the same group (65.2% versus 51.3%; p=0.02). The estimated hospital days saved was 1001 days over 3 years. Conclusion: A dedicated malignant pleural effusion (MPE) clinic is a strategy of malignant effusion management that reduces hospital admission days and, will allow patients to spend more time outside hospital, reduce costs and save healthcare resources. Outpatient MPE clinic is of particular importance in the setting of the health care system and the overcrowded hospitals. The ability to avoid a one week hospitalization for a palliative intervention and replace it with a simple and effective outpatient procedure should appeal to patients and administrators alike.
Background and Objectives: Cardiovascular disease (CVD) is a major contributor to the high mortality rate among individuals with ovarian cancer. Nevertheless, there is limited understanding regarding the specific patient attributes that might impact the risk of CVD in this group. Materials and Methods: A retrospective cohort study was performed using the SEER database to analyze primary ovarian cancer cases from 2000 to 2019. Multivariable logistic regression analysis was employed to identify patient characteristics linked to cardiovascular mortality. Results: The cohort included 41,930 cases of patients who were alive, 54,829 cases of cancer-related deaths, 3003 cases of cardiovascular-related deaths, and 10,238 cases with other causes of death. Poorly differentiated cancer cells and distant metastasis were associated with a higher risk of cardiovascular mortality. Logistic regression analysis identified age, year of diagnosis, race, laterality, and staging as significant risk factors for cardiovascular cause of death. The risk of cardiovascular cause of death was lower in patients aged 31–60 and higher in those aged over 60 years old, and the risk also increased with a later year of diagnosis. Patients who were not white were at a higher risk of cardiovascular cause of death. Additionally, bilateral ovarian cancer and distant staging disease were linked to elevated risks of cardiovascular cause of death. Conclusion: Cardiovascular mortality is a significant concern in ovarian cancer patients, and several patient characteristics are associated with an increased risk. Our study suggests that targeted interventions to improve cardiovascular health in high-risk patients, such as those with comorbidities or an advanced stage at diagnosis, may improve survival in this population.
COVID-19 infection has a spectrum of variable clinical severity between populations because of their characteristic demographic features, co-morbidities, and immune system reactions. This pandemic tested the healthcare system's preparedness, which depends on predictors of severity and factors related to the duration of hospital stays. Therefore, we carried out a single-center, retrospective cohort study in a tertiary academic hospital to investigate these clinical features and predictors of severe disease and study the different factors that affect hospital stay. We utilized medical records from March 2020 to July 2021, which included 443 confirmed (positive RT-PCR) cases. The data were explained using descriptive statistics and analyzed via multivariate models. Among the patients, 65.4% were female and 34.5% were male, with a mean age of 45.7 years (SD ± 17.2). We presented seven age groups with ranges of 10 years and noticed that patients aged 30-39 years old comprised 23.02% of the records, while patients aged 70 and above comprised 10%. Nearly 47% were diagnosed as having mild, 25% as moderate, 18% as asymptomatic, and 11% as having a severe case of COVID-19 disease. Diabetes was the most common co-morbidity factor in 27.6% of patients, followed by hypertension (26.4%). Our population's predictors of severity included pneumonia, identified on a chest X-ray, and co-morbid conditions such as cardiovascular disease, stroke, ICU stay, and mechanical ventilation. The median length of hospital stay was six days. It was significantly longer in patients with a severe disease and who were administered systemic intravenous steroids. An empirical assessment of various clinical parameters could assist in effectively measuring the disease progression and follow-up with patients.
Clinical and Applied Thrombosis/Hemostasis · مجلد 29 · 10760296231218216-10760296231218216
The use of erythropoietin-stimulating agents (ESAs) as adjunctive therapy in critically ill patients with COVID-19 may have a potential benefit. This study aims to evaluate the effect of ESAs on the clinical outcomes of critically ill COVID-19 patients. A multicenter, retrospective cohort study was conducted from 01-03-2020 to 31-07-2021. We included adult patients who were ≥ 18 years old with a confirmed diagnosis of COVID-19 infection and admitted to intensive care units (ICUs). Patients were categorized depending on ESAs administration during their ICU stay. The primary endpoint was the length of stay; other endpoints were considered secondary. After propensity score matching (1:3), the overall included patients were 120. Among those, 30 patients received ESAs. A longer duration of ICU and hospital stay was observed in the ESA group (beta coefficient: 0.64; 95% CI: 0.31-0.97; P = < .01, beta coefficient: 0.41; 95% CI: 0.12-0.69; P = < .01, respectively). In addition, the ESA group's ventilator-free days (VFDs) were significantly shorter than the control group. Moreover, patients who received ESAs have higher odds of liver injury and infections during ICU stay than the control group. The use of ESAs in COVID-19 critically ill patients was associated with longer hospital and ICU stays, with no survival benefits but linked with lower VFDs.
recombinant human erythropoietinerythropoiesis-stimulating agentsCOVID-19 pandemiccritically ill patients
Purpose: Optimal adherence to antidiabetics among patients with type 2 diabetes mellitus has been associated with positive health outcomes; however, studies to assess this adherence in Saudi Arabia are scarce. We aimed to evaluate adherence to antidiabetics using a Saudi population. Methods: This was a multicenter, retrospective cohort study of patients (≥ 18 years old) with type 2 diabetes mellitus who received ≥ 1 antidiabetic between 2015 and 2020. Adherence was estimated using the continuous multiple-interval measure of medication availability (CMA7). A CMA7 cutoff point of ≥ 80% was chosen to define optimal adherence, and the odds of not achieving therapeutic annual HbA1c levels (i.e. ≥ 7%) in the optimal vs. suboptimal adherence groups was assessed using a logistic regression model adjusting for the measured confounders. Results: A total of 36,789 patients were included in the study. The most commonly prescribed regimens were metformin single treatment (n=15,025 [41.6%]) and gliclazide-metformin combination treatment (n=5,667 [15.7%]). The median CMA7 was 70.4%, and only 13,552 (36.9%) patients were adherent to their antidiabetics (CMA7 ≥ 80%). The odds of not achieving therapeutic HbA1c levels one year after the index date were comparable in the optimal vs. suboptimal adherence groups (odds ratio = 0.99, 95% confidence interval 0.92 to 1.05). Conclusions: This study showed that a large proportion of a Saudi population with type 2 diabetes mellitus were non-adherent to their antidiabetic treatments. Future Saudi and regional studies are needed to assess the impact of adherence on HbA1c levels and on cardiovascular outcomes.
type 2 diabetesantidiabetic medication adherencemedication non-adherenceHbA1c control
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system. It is an autoimmune disease of multifactorial etiology, linked to a variety of genetic and well-defined environmental factors. It typically affects more women than men and more frequently affects adults aged 20–45 years. Besides, vitamin B12 deficiency and obesity are associated with exacerbating central nervous system inflammation and a higher clinical disability. The study aims to determine the association of the vitamin B12 serum concentration with the Body Mass Index BMI, thyroid-stimulating hormone serum levels and MS clinical features in Saudi MS patients. This is a retrospective cohort study, and data were collected from the MS database at the King Fahad Medical City Multiple Sclerosis Clinic, from December 2015 to December 2019. Data were entered and analyzed using the Statistical Package for Social Sciences (SPSS ver. 20, Chicago, IL, USA). Cobalamin, also known as vitamin B12, has a reference concentration that ranges from 138 to 652 Pmol/L in adults. The patient's BMI was calculated by dividing the weight (in kilograms) by the square of the height (in square meters), expressed in kg/m2. Data for 169 MS subjects were collected. A total 83 of them, with a mean age of 36.2 ± 9.57 years, had vitamin B12 results. Of all patients, 16.6% had vitamin B12 deficiency (<138 pmol/L) and 9.52% of them were overweight, BMI kg/m2 = (25–29.9). The mean vitamin B12 level in all MS subjects was 240 ± 117 pmol/L. Moreover, 58.33% of the MS patients had high BMIs (BMI >25). However, no significant correlation was found between vitamin B12 deficiency neither with the BMI nor TSH concentration in MS cases (r = 0.03, p = 0.64), (r = 0.00, P = 0.9) respectively. These findings revealed no association between serum vitamin B12 concentration and TSH, BMI in MS clinical parameters, however, further studies are required to validate these results.
multiple sclerosisvitamin B12 deficiencyvitamin B12body mass index
Plastic & Reconstructive Surgery Global Open · مجلد 10 (10) · e4576-e4576
Background: Factors like parent satisfaction and expert opinion have been proposed as outcome measures related to craniosynostosis (CS) surgery. However, there is no real tangible score for CS surgery outcomes. In our study, we aimed to explore different factors considered as a tangible outcome measure of CS surgery. Methods: A retrospective cohort study of 23 patients with CS who were operated on in a tertiary care university hospital. Parents were interviewed to assess their satisfaction of aesthetic outcome. This was correlated to two expert opinions and to the amount of skull expansion. Results: The mean follow-up duration was 2.24 ± 1.12 years. Twelve of the 23 fathers were satisfied, whereas 11 of the 23 mothers were satisfied. The overall combined satisfaction rate of both parents was on the higher side with no difference in between. There was a significant association between expansion rate of 7.65 ± 4.99% and the overall parent’s satisfaction (P = 0.002). Additionally, there was a good correlation between both experts with statistically significant association (P = 0.004). No correlation was found between the parents’ satisfaction and the experts’ opinions. Conclusions: The study is valuable, as it investigates the relationship between the expansion rate, parents’ satisfaction, and expert opinion as predicted values of craniosynostosis surgery. The overall satisfaction correlated significantly well with the expansion rate. However, such numerical assessment is not a real guide for assessing clinical outcomes‚ as no association was found between expansion rate, satisfaction rate, and expert opinion.